Related Experiment Video
Updated: Sep 16, 2025

Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
The Impact of Volume Removal by Hemodialysis on Elevated NT-proBNP Levels in Patients With Hypervolemia
Mohammad Tinawi1, Bahar Bastani2
1Nephrology, Nephrology Specialists, Munster, USA.
Introduction And Aim:
N-terminal pro-brain-type natriuretic peptide (NT-proBNP) is highly sensitive and specific for the diagnosis of congestive heart failure (CHF). Most patients with end-stage kidney disease (ESKD) on renal replacement therapy have an elevated NT-proBNP plasma level due to volume gain between dialysis sessions. Measuring plasma NT-proBNP levels before and after hemodialysis (HD) in patients hospitalized with volume expansion is a common practice. This study aimed to determine the clinical value of repeated plasma NT-proBNP measurements in patients with ESKD or acute kidney injury (AKI) requiring HD and to study the effect of volume removal via HD on NT-proBNP plasma levels.
Methods:
We conducted a retrospective analysis of patients admitted to two community hospitals over a three-year period (from January 1, 2020, to December 31, 2022). Patients with AKI requiring HD or ESKD were screened if they had an admission diagnosis of volume expansion including acute CHF or pulmonary edema that was verified radiographically and by physical examination. Patients who had a plasma NT-proBNP level measured at admission and a repeat measurement 2-12 hours after HD were included in this study. Over the three-year period, 36 patients with ESKD and five patients with AKI requiring HD fulfilled the inclusion criteria.
Results:
Volume removal via HD had no impact on NT-proBNP levels in ESKD or AKI patients (ESKD p=0.7858 and AKI p=0.6903). Our patients exhibited markedly elevated NT-proBNP due to volume expansion and renal dysfunction. During the study period, 30% of the patients with ESKD (11/36) died.
Conclusion:
Volume expansion is the main factor causing elevated NT-proBNP levels in acute or chronic HD patients. Reducing predialysis volume expansion with a single hemodialysis session has no impact on NT-proBNP level. Therefore, repeating the NT-proBNP level post-HD has no clinical value. Our data suggest that NT-proBNP is a useful cardiac biomarker for volume expansion, and its elevated level predicts high cardiovascular mortality and recurrent hospitalizations in acute and chronic HD patients.
More Related Videos
04:36Measurement of Tissue Oxygenation Using Near-Infrared Spectroscopy in Patients Undergoing Hemodialysis
Published on: October 2, 2020
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Related Concept Videos
Hemodialysis III: Nursing Management
Hemodialysis II: Procedure and Complications
Antihypertensive Drugs: Action of Diuretics
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management